Boost your knowledge
Specialized Clinical Services for Complex Clinical Studies
Specialized Services For Complex Clinical Studies
Lonza and Israel Biotech Fund Collaboration Framework Agreement to Support Biologics and Small...
Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech...
Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation...
Oasmia Signs Manufacturing Agreement with Lonza for Ovarian Cancer Drug Candidate Cantrixil
Lonza, Forbion, and BioGeneration Ventures Extend Collaboration to Add Development and Manufacturing...
A service center for formulation, clinical and commercial manufacturing
Tampa, FL, USA
Our facilities in Tampa (FL) US are an integral component of our design, development and manufacturing network for drug substances and specialized drug products. Working collaboratively with our customers, our Tampa team designs, develops and manufactures tablets and encapsulated formulations for immediate and modified release applications. The site provides a full range of services from preformulation and formulation development through clinical and commercial scale production of specialized drug products, inclusive of analytical method development, and packaging and logistics services for clinical supplies.
Tampa serves as our US Center of Excellence for rapid first-in-human services utilizing Powder-in-Capsule and Powder-in-Bottle formulations based on our proprietary Xcelodose® Precision Powder Micro-Dosing Technology. Lonza has Xcelodose® capacity in place for non-cGMP development studies and cGMP clinical manufacturing. Large scale encapsulation (Harro Hoefliger Modu C) processing is also in place to ensure accelerated pathway to commercialization where required.